Thu. 9 May 2024, 4:50pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) by 13.33 percent. This is a 18.75 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $1.910 million which missed the analyst consensus estimate of $2.521 million by 24.24 percent. This is a 2.69 percent increase over sales of $1.860 million the same period last year.